On its first quarter earnings call J&J singled out its Varipulse pulsed field ablation catheter as a crucial product to sustain growth. Pulsed field ablation, a treatment for atrial fibrillation, is safer than current ablation techniques and is expected to replace them in the next few years.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,